Management of dyspepsia and Helicobacter pylori infection: the 2022 Indonesian Consensus Report

[1]  J. Akada,et al.  Low-grade intestinal metaplasia in Indonesia: Insights into the expression of proinflammatory cytokines during Helicobacter pylori infection and unique East-Asian CagA characteristics. , 2023, Cytokine.

[2]  M. Miftahussurur,et al.  Macronutrient and micronutrient intake in dietary habits contributed to dyspeptic symptoms in Indonesia , 2022, Gaceta Médica de Caracas.

[3]  N. Freemantle,et al.  Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE): A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19 , 2022, medRxiv.

[4]  M. Law,et al.  Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases , 2021, World journal of hepatology.

[5]  Y. Yamaoka,et al.  Pepsinogen and Serum IgG Detection Is a Valuable Diagnostic Method for Helicobacter pylori Infection in a Low-Prevalence Country: A Report from Sri Lanka , 2021, Diagnostics.

[6]  Y. Yamaoka,et al.  Helicobacter pylori in the Indonesian Malay’s descendants might be imported from other ethnicities , 2021, Gut Pathogens.

[7]  Y. Yamaoka,et al.  CYP2C19 Polymorphisms in Indonesia: Comparison among Ethnicities and the Association with Clinical Outcomes , 2021, Biology.

[8]  E. Kandil,et al.  Gastroenterology manifestations and COVID‐19 outcomes: A meta‐analysis of 25,252 cohorts among the first and second waves , 2021, Journal of medical virology.

[9]  Z. Xia,et al.  Gastrointestinal Symptoms Associated With Unfavorable Prognosis of COVID-19 Patients: A Retrospective Study , 2020, Frontiers in Medicine.

[10]  J. Gisbert.  Empirical or susceptibility-guided treatment for Helicobacter pylori infection? A comprehensive review , 2020, Therapeutic advances in gastroenterology.

[11]  H. Ashrafian,et al.  The endoscopic predictors of Helicobacter pylori status: a meta-analysis of diagnostic performance , 2020, Therapeutic advances in gastrointestinal endoscopy.

[12]  P. Malfertheiner,et al.  Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus , 2020, Gut.

[13]  A. Syam,et al.  A Clinical and Procedural Guideline for Gastrointestinal Endoscopy Units during COVID-19 Pandemic Era. , 2020, Acta medica Indonesiana.

[14]  D. Orgill,et al.  Adherence to Personal Protective Equipment Guidelines During the COVID-19 Pandemic: A Worldwide Survey Study , 2020, The British journal of surgery.

[15]  A. Khomsan,et al.  Overview of Helicobacter pylori Infection in Indonesia: What Distinguishes It from Countries with High Gastric Cancer Incidence? , 2020, Gut and liver.

[16]  Chengwei Tang,et al.  Management of Digestive Disorders and Procedures Associated With COVID-19 , 2020, The American journal of gastroenterology.

[17]  A. Wirya,et al.  Urticarial manifestation in COVID-19 infection: A case report , 2020 .

[18]  S. Xiao,et al.  Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies , 2020, Modern Pathology.

[19]  Y. Yamaoka,et al.  E-test versus agar dilution for antibiotic susceptibility testing of Helicobacter pylori: a comparison study , 2020, BMC Research Notes.

[20]  T. Gotoda,et al.  Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan , 2020, Gut.

[21]  S. Setiati,et al.  Gastrointestinal Presentation in COVID-19 in Indonesia: A Case Report. , 2020, Acta medica Indonesiana.

[22]  O. Adeniyi,et al.  Use of alarm features in predicting significant endoscopic findings in Nigerian patients with dyspepsia , 2019, The Pan African medical journal.

[23]  B. Hernowo,et al.  Low-Stage Gastric MALT Lymphoma Causing Life-Threatening Upper Gastrointestinal Bleeding , 2019, Case Reports in Gastroenterology.

[24]  D. Graham,et al.  Gastric cancer risk stratification and surveillance after Helicobacter pylori eradication: 2020. , 2019, Gastrointestinal endoscopy.

[25]  M. Leja,et al.  Review: Epidemiology of Helicobacter pylori infection , 2019, Helicobacter.

[26]  J. Nishikawa,et al.  Efficacy of Vonoprazan for Helicobacter pylori Eradication , 2019, Internal medicine.

[27]  Y. Yamaoka,et al.  Analysis of risks of gastric cancer by gastric mucosa among Indonesian ethnic groups , 2019, PloS one.

[28]  Youming Li,et al.  Alternative eradication regimens for Helicobacter pylori infection in Indonesian regions with high metronidazole and levofloxacin resistance , 2019, Infection and drug resistance.

[29]  J. Emile,et al.  Contribution of genetic amplification by PCR for the diagnosis of Helicobacter pylori infection in patients receiving proton pump inhibitors , 2018, United European gastroenterology journal.

[30]  V. Stanghellini.  Functional Dyspepsia and Irritable Bowel Syndrome: Beyond Rome IV , 2018, Digestive Diseases.

[31]  D. Graham,et al.  Helicobacter pylori management in ASEAN: The Bangkok consensus report , 2018, Journal of gastroenterology and hepatology.

[32]  O. Amaral,et al.  Living Conditions and Helicobacter pylori in Adults , 2017, BioMed research international.

[33]  P. Moayyedi,et al.  ACG and CAG Clinical Guideline: Management of Dyspepsia , 2017, The American Journal of Gastroenterology.

[34]  A. Syam,et al.  National Consensus on Management of Dyspepsia and Helicobacter pylori Infection. , 2017, Acta medica Indonesiana.

[35]  Hidekazu Suzuki.  The Application of the Rome IV Criteria to Functional Esophagogastroduodenal Disorders in Asia , 2017, Journal of neurogastroenterology and motility.

[36]  Z. Zeng,et al.  Fifth Chinese National Consensus Report on the management of Helicobacter pylori infection , 2017, Helicobacter.

[37]  D. Graham,et al.  Helicobacter, Hygiene, Atopy, and Asthma , 2017, Front. Microbiol..

[38]  J. Tack,et al.  Rome III functional dyspepsia symptoms classification: Severity vs frequency , 2017, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[39]  Y. Jung,et al.  Systematic review with meta‐analysis: the efficacy of vonoprazan‐based triple therapy on Helicobacter pylori eradication , 2017, Alimentary pharmacology & therapeutics.

[40]  Y. Yamaoka,et al.  Gastric mucosal status in populations with a low prevalence of Helicobacter pylori in Indonesia , 2017, PloS one.

[41]  D. Drossman,et al.  What Is New in Rome IV , 2017, Journal of neurogastroenterology and motility.

[42]  W. Chey,et al.  Clinical Guideline : Treatment of Helicobacter pylori Infection , 2017 .

[43]  M. Burkitt,et al.  Helicobacter pylori-induced gastric pathology: insights from in vivo and ex vivo models , 2017, Disease Models & Mechanisms.

[44]  Yoshio Yamaoka,et al.  Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations , 2016, PloS one.

[45]  K. Kusmardi,et al.  Comparison of Helicobacter pylori Detection Using Immunohistochemistry and Giemsa and Its Association with Morphological Changes in Active Chronic Gastritis , 2016 .

[46]  R. Hunt,et al.  Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report , 2016, Gut.

[47]  S. Sasazuki.  The ABC Method and Gastric Cancer: Evidence From Prospective Studies , 2016, Journal of epidemiology.

[48]  R. Hunt,et al.  The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. , 2016, Gastroenterology.

[49]  Meng Chen,et al.  Antidepressants in the Treatment of Functional Dyspepsia: A Systematic Review and Meta-Analysis , 2016, PloS one.

[50]  Jan Tack,et al.  Gastroduodenal Disorders. , 2016, Gastroenterology.

[51]  Y. Yamaoka,et al.  Diagnostic Methods of Helicobacter pylori Infection for Epidemiological Studies: Critical Importance of Indirect Test Validation , 2016, BioMed research international.

[52]  Y. Yamaoka,et al.  Risk Factors and Prevalence of Helicobacter pylori in Five Largest Islands of Indonesia: A Preliminary Study , 2015, PloS one.

[53]  Deng-Chyang Wu,et al.  Diagnosis of Helicobacter pylori infection: Current options and developments. , 2015, World journal of gastroenterology.

[54]  P. Malfertheiner,et al.  Kyoto global consensus report on Helicobacter pylori gastritis , 2015, Gut.

[55]  K. Haruma,et al.  [Helicobacter pylori infection and endoscopic gastritis -Kyoto classification of gastritis]. , 2015, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

[56]  D. Sadowski,et al.  Dyspepsia , 2015, Canadian Medical Association Journal.

[57]  M. Byrne,et al.  Extraintestinal manifestations of Helicobacter pylori: a concise review. , 2014, World journal of gastroenterology.

[58]  P. Moayyedi,et al.  Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis , 2014, Gut.

[59]  C. O'Morain,et al.  Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance. , 2014, World journal of gastroenterology.

[60]  Y. Yamaoka,et al.  Identification of Helicobacter pylori infection in symptomatic patients in Surabaya, Indonesia, using five diagnostic tests , 2014, Epidemiology and Infection.

[61]  D. Graham.  History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. , 2014, World journal of gastroenterology.

[62]  D. Makmun.  Present status of endoscopy, therapeutic endoscopy and the endoscopy training system in Indonesia , 2014, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[63]  R. Sharaf,et al.  Contaminated water as a source of Helicobacter pylori infection: A review , 2013, Journal of advanced research.

[64]  Haoxuan Zheng,et al.  Meta-analysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease , 2013, European journal of gastroenterology & hepatology.

[65]  J. Gisbert,et al.  Helicobacter Pylori “Test-and-Treat” Strategy for Management of Dyspepsia: A Comprehensive Review , 2013, Clinical and Translational Gastroenterology.

[66]  C. Mcnulty,et al.  Is Helicobacter pylori antibiotic resistance surveillance needed and how can it be delivered? , 2012, Alimentary pharmacology & therapeutics.

[67]  K. Sugano,et al.  Asian Consensus Report on Functional Dyspepsia , 2012, Journal of neurogastroenterology and motility.

[68]  K. Sugano,et al.  Asian consensus report on functional dyspepsia , 2012, Journal of gastroenterology and hepatology.

[69]  Z. Tulassay,et al.  Update on the pharmacogenomics of proton pump inhibitors. , 2011, Pharmacogenomics.

[70]  A. Syam,et al.  Helicobacter pylori infection: prevalence in chronic urticaria patients and incidence of autoimmune urticaria (study in Dr. Cipto Mangunkusumo Hospital, Jakarta). , 2007, Acta medica Indonesiana.

[71]  Reza Ghadimi,et al.  Helicobacter pylori infection appears essential for stomach carcinogenesis: Observations in Semarang, Indonesia , 2005, Cancer science.

[72]  T. Mine,et al.  Effect of Helicobacter pylori Eradication in Patients with Chronic Idiopathic Thrombocytopenic Purpura—A Randomized Controlled Trial , 2005, The American Journal of Gastroenterology.

[73]  T. Azuma,et al.  Rare Helicobacter pylori infection as a factor for the very low stomach cancer incidence in Yogyakarta, Indonesia. , 2005, Cancer letters.

[74]  A. Syam,et al.  Accuracy of Helicobacter pylori stool antigen for the detection of Helicobacter pylori infection in dyspeptic patients. , 2005, World journal of gastroenterology.

[75]  Y. Matsuzawa,et al.  Helicobacter pylori‐induced enlarged‐fold gastritis is associated with increased mutagenicity of gastric juice, increased oxidative DNA damage, and an increased risk of gastric carcinoma , 2003, Journal of gastroenterology and hepatology.

[76]  Savarino,et al.  The impact of antibiotic resistance on the efficacy of three 7‐day regimens against Helicobacter pylori , 2000, Alimentary pharmacology & therapeutics.

[77]  A. Fraser,et al.  Follow up after successful eradication of Helicobacter pylori: Symptoms and reinfection , 1998, Journal of gastroenterology and hepatology.

[78]  P. Bytzer.  Can Noninvasive Helicobacter pylori Testing Save Endoscopy? , 1997, Endoscopy.

[79]  C. O'Morain,et al.  Helicobacter pylori Infection , 1994 .

[80]  D. Graham,et al.  Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. , 1994, Gastrointestinal endoscopy.

[81]  K. Iwakiri,et al.  Management of functional dyspepsia: state of the art and emerging therapies , 2018, Therapeutic advances in chronic disease.

[82]  G. Khor,et al.  Sodium Consumption in Southeast Asia: An Updated Review of Intake Levels and Dietary Sources in Six Countries , 2015 .

[83]  J. Brill,et al.  American Gastroenterological Association Institute Guideline on the Role of Upper Gastrointestinal Biopsy to Evaluate Dyspepsia in the Adult Patient in the Absence of Visible Mucosal Lesions. , 2015, Gastroenterology.

[84]  D. Graham,et al.  Diagnosis of Helicobacter pylori using the rapid urease test. , 2015, Annals of translational medicine.

[85]  B. Braden,et al.  Helicobacter Pylori Infection: Diagnostic Strategies in Primary Diagnosis and After Therapy , 2015, Digestive Diseases and Sciences.

[86]  Jan Tack,et al.  Gastroduodenal Disorders , 2010, The American Journal of Gastroenterology.

[87]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[88]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[89]  J. Freudenheim,et al.  Diet in the epidemiology of gastric cancer. , 1990, Nutrition and cancer.